Learn about conventional, complementary, and integrative therapies.
Dealing with treatment side effects? Learn about evidence-based therapies to alleviate your symptoms.
Click the orange button to the right to learn more.
The title “astragalus prevents chemo-induced immune injury” may be a broad statement but it is what came in to my mind as I read the study linked below.
For years now, I have been struggling with the idea that chemotherapy (all forms, all types) are a short term solution to the problem of cancer. Yes, chemo kills cancer cells but, at the same time, chemo damages the patient’s immune system.
If the cancer patient has to undergo successive rounds of chemo, their immune system is damaged repeatedly until they are as susceptible to infection as they are to their cancer.
I know this is true with my cancer, multiple myeloma. MM is an incurable blood cancer. MM patients live through remissions and relapses undergoing round after round of chemo.
Conventional oncology focuses on treating cancer not side effect prevention. Information like this post, while based on research, is outside of the usual purview of conventional oncology. Remember that your oncologist will know little about evidence-based non-conventional therapies such as astragalus.
Pros:
Cons:
My thinking is that if astragalus prevents chemo-induced immune injury, then cancer patients can add this therapy to their regimen of nutrition, nutritional supplementation and life style therapies in order to undergo chemo and keep their immune system as healthy as possible at the same time.
We will see. Cross your fingers. If you are a cancer patient and you have questions about enhancing your immune system email me at David.PeopleBeatingCancer@gmail.com
thank you,
David Emerson
“The damage of chemotherapy drugs to immune function and intestinal mucosa is a common side effect during chemotherapy. Astragalus polysaccharides (APS) exhibit immunomodulatory properties and are recognized for preserving the integrity of the human intestinal barrier. Nevertheless, their application and mechanisms of action in chemotherapy-induced immune damage and intestinal barrier disruption remain insufficiently explored…
APS ameliorated chemotherapy-induced damage to immune organs and regulated immune cell differentiation disorders, including CD4+T, CD8+T, CD19+B, F4/80+CD11B+ macrophages. APS also alleviated colon shortening and upregulated the expression of intestinal barrier proteins.
Furthermore, APS significantly restored structure of gut microbiota following chemotherapy intervention. Ex vivo microbiome assays further demonstrated the capacity of APS to improve 5-Fu-induced microbiota growth inhibition and compositional change. FMT demonstrated that the regulation of gut microbiota by APS could promote the recovery of immune functions and alleviate shortening of the colon length.
Remarkably, APS significantly ameliorated the imbalance of linoleic acid (LA) and α-linolenic acid in polyunsaturated fatty acid (PUFA) metabolism. Further in vitro experiments showed that LA could promote splenic lymphocyte proliferation. In addition, both LA and DGLA down-regulated the secretion of NO and partially up-regulated the percentage of F4/80+CD11B+CD206+ cells.
Astragalus prevents chemo-induced immune Injury and intestinal mucosal disruption by regulating the composition of the gut microbiota and further restoring PUFA metabolism.
These findings indicate that APS can serve as an adjuvant to improve the side effects such as intestinal and immune damage caused by chemotherapy…